TODAY'S NEWS

Alectinib Approved as Adjuvant Treatment...

On April 18, the U.S. Food and Drug Administration...

---

Professional Societies Introduce New Evi...

The College of American Pathologists in collaborat...

---

Accelerated Aging May Be a Risk Factor f...

According to recent studies, the incidence of earl...

---

Novel MDM2 Inhibitor Shows Activity in S...

A novel MDM2 inhibitor has demonstrated antitumor ...

---

Novel SPECT/CT Imaging Technique Under S...

A novel single-photon emission computed tomography...

More News From Today

EDITORIALS & COMMENTARY

Advanced Practitioners as Allies and Advocates

Advanced practitioners (APs) are a growing proportion of the health-care team...

---

Rare Myeloproliferative Neoplasm w/CSF3R

Cases of chronic neutrophilic leukemia (CNL) are extremely rare and easily missed...

---

Management of Carcinoid Syndrome

Diarrhea is often a presenting symptom in patients with neuroendocrine tumors...

---

APs: Collaborators in Radiation Oncology

Advanced practitioners, including physician assistants and nurse practitioners, are medical professionals with...

---

Axicabtagene Ciloleucel: CAR T-Cell Therapy

Axicabtagene ciloleucel (axi-cel) is an anti-CD19 CAR T-cell therapy that has demonstrated efficacy...

More Editorials & Commentary

PREVIOUS HIGHLIGHTS

Gemcitabine/Eribulin in Cisplatin-Inelig...

In the final analysis from a phase II California C...

---

Deintensified Chemoradiotherapy for HPV-...

In a phase II trial reported in the Journal of Cli...

---

USPSTF Recommendation on Risk Assessment...

As reported in JAMA, the U.S. Preventive Services ...

---

Incidence of HPV-Associated Head and Nec...

In a study by Mahal et al published in Cancer Epid...

---

Racial Reporting and Representation in O...

New research published by Loree et al in JAMA Onco...

More Highlights

LATEST TWEETS

Error loading Partial View script (file: ~/Views/MacroPartials/JADPRO Twitter Feed.cshtml)

More Tweets